SNES Key Statistics, Chart & Performance
The current stock price of SNES is 2.77 USD. In the past month the price decreased by -7.36%. In the past year, price decreased by -29.7%.
SNES Latest News, Press Relases and Analysis
SNES Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 45.9 | 954.25B | ||
| JNJ | JOHNSON & JOHNSON | 20.23 | 505.98B | ||
| MRK | MERCK & CO. INC. | 11.24 | 245.74B | ||
| PFE | PFIZER INC | 8.06 | 146.69B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 7.8 | 104.23B | ||
| ZTS | ZOETIS INC | 18.56 | 51.85B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.44 | 22.40B | ||
| VTRS | VIATRIS INC | 4.97 | 13.35B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 22.16 | 10.57B | ||
| CORT | CORCEPT THERAPEUTICS INC | 99.01 | 9.17B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 7.50B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 5.24B |
Related stock screener links
About SNES
Company Profile
SenesTech, Inc. engages in the development and commercialization of proprietary technology for the management of animal pest populations. The company is headquartered in Phoenix, Arizona and currently employs 23 full-time employees. The company went IPO on 2016-12-08. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption.
Company Info
SENESTECH INC
777 W. Pinnacle Peak Road, Suite B104
Phoenix ARIZONA 85027 US
CEO: Kenneth Siegel
Employees: 23
Phone: 19287794143
SENESTECH INC / SNES FAQ
What does SNES do?
SenesTech, Inc. engages in the development and commercialization of proprietary technology for the management of animal pest populations. The company is headquartered in Phoenix, Arizona and currently employs 23 full-time employees. The company went IPO on 2016-12-08. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption.
Can you provide the latest stock price for SENESTECH INC?
The current stock price of SNES is 2.77 USD. The price decreased by -5.14% in the last trading session.
What is the dividend status of SENESTECH INC?
SNES does not pay a dividend.
What is the ChartMill technical and fundamental rating of SNES stock?
SNES has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Can you provide the growth outlook for SENESTECH INC?
The Revenue of SENESTECH INC (SNES) is expected to grow by 24.9% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the employee count for SNES stock?
SENESTECH INC (SNES) currently has 23 employees.
Can you provide the upcoming earnings date for SENESTECH INC?
SENESTECH INC (SNES) will report earnings on 2026-03-10, after the market close.
SNES Technical Analysis
SNES Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to SNES. While SNES seems to be doing ok healthwise, there are quite some concerns on its profitability.
SNES Financial Highlights
Over the last trailing twelve months SNES reported a non-GAAP Earnings per Share(EPS) of -9.97. The EPS increased by 96.76% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -39.89% | ||
| ROE | -51.41% | ||
| Debt/Equity | 0.01 |
SNES Forecast & Estimates
7 analysts have analysed SNES and the average price target is 10.2 USD. This implies a price increase of 268.23% is expected in the next year compared to the current price of 2.77.
For the next year, analysts expect an EPS growth of 72.07% and a revenue growth 24.9% for SNES